1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biosimilar Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Tablet 1.2.3 Oral Solution 1.3 Market by Application 1.3.1 Global Biosimilar Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Pharmacy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Biosimilar Market Perspective (2016-2027) 2.2 Biosimilar Growth Trends by Regions 2.2.1 Biosimilar Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Biosimilar Historic Market Share by Regions (2016-2021) 2.2.3 Biosimilar Forecasted Market Size by Regions (2022-2027) 2.3 Biosimilar Industry Dynamic 2.3.1 Biosimilar Market Trends 2.3.2 Biosimilar Market Drivers 2.3.3 Biosimilar Market Challenges 2.3.4 Biosimilar Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Biosimilar Players by Revenue 3.1.1 Global Top Biosimilar Players by Revenue (2016-2021) 3.1.2 Global Biosimilar Revenue Market Share by Players (2016-2021) 3.2 Global Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Biosimilar Revenue 3.4 Global Biosimilar Market Concentration Ratio 3.4.1 Global Biosimilar Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Revenue in 2020 3.5 Biosimilar Key Players Head office and Area Served 3.6 Key Players Biosimilar Product Solution and Service 3.7 Date of Enter into Biosimilar Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Biosimilar Breakdown Data by Type 4.1 Global Biosimilar Historic Market Size by Type (2016-2021) 4.2 Global Biosimilar Forecasted Market Size by Type (2022-2027) 5 Biosimilar Breakdown Data by Application 5.1 Global Biosimilar Historic Market Size by Application (2016-2021) 5.2 Global Biosimilar Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Biosimilar Market Size (2016-2027) 6.2 North America Biosimilar Market Size by Type 6.2.1 North America Biosimilar Market Size by Type (2016-2021) 6.2.2 North America Biosimilar Market Size by Type (2022-2027) 6.2.3 North America Biosimilar Market Size by Type (2016-2027) 6.3 North America Biosimilar Market Size by Application 6.3.1 North America Biosimilar Market Size by Application (2016-2021) 6.3.2 North America Biosimilar Market Size by Application (2022-2027) 6.3.3 North America Biosimilar Market Size by Application (2016-2027) 6.4 North America Biosimilar Market Size by Country 6.4.1 North America Biosimilar Market Size by Country (2016-2021) 6.4.2 North America Biosimilar Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Biosimilar Market Size (2016-2027) 7.2 Europe Biosimilar Market Size by Type 7.2.1 Europe Biosimilar Market Size by Type (2016-2021) 7.2.2 Europe Biosimilar Market Size by Type (2022-2027) 7.2.3 Europe Biosimilar Market Size by Type (2016-2027) 7.3 Europe Biosimilar Market Size by Application 7.3.1 Europe Biosimilar Market Size by Application (2016-2021) 7.3.2 Europe Biosimilar Market Size by Application (2022-2027) 7.3.3 Europe Biosimilar Market Size by Application (2016-2027) 7.4 Europe Biosimilar Market Size by Country 7.4.1 Europe Biosimilar Market Size by Country (2016-2021) 7.4.2 Europe Biosimilar Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Biosimilar Market Size (2016-2027) 8.2 Asia-Pacific Biosimilar Market Size by Type 8.2.1 Asia-Pacific Biosimilar Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Biosimilar Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Biosimilar Market Size by Type (2016-2027) 8.3 Asia-Pacific Biosimilar Market Size by Application 8.3.1 Asia-Pacific Biosimilar Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Biosimilar Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Biosimilar Market Size by Application (2016-2027) 8.4 Asia-Pacific Biosimilar Market Size by Region 8.4.1 Asia-Pacific Biosimilar Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Biosimilar Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Biosimilar Market Size (2016-2027) 9.2 Latin America Biosimilar Market Size by Type 9.2.1 Latin America Biosimilar Market Size by Type (2016-2021) 9.2.2 Latin America Biosimilar Market Size by Type (2022-2027) 9.2.3 Latin America Biosimilar Market Size by Type (2016-2027) 9.3 Latin America Biosimilar Market Size by Application 9.3.1 Latin America Biosimilar Market Size by Application (2016-2021) 9.3.2 Latin America Biosimilar Market Size by Application (2022-2027) 9.3.3 Latin America Biosimilar Market Size by Application (2016-2027) 9.4 Latin America Biosimilar Market Size by Country 9.4.1 Latin America Biosimilar Market Size by Country (2016-2021) 9.4.2 Latin America Biosimilar Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Biosimilar Market Size (2016-2027) 10.2 Middle East & Africa Biosimilar Market Size by Type 10.2.1 Middle East & Africa Biosimilar Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Biosimilar Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Biosimilar Market Size by Type (2016-2027) 10.3 Middle East & Africa Biosimilar Market Size by Application 10.3.1 Middle East & Africa Biosimilar Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Biosimilar Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Biosimilar Market Size by Application (2016-2027) 10.4 Middle East & Africa Biosimilar Market Size by Country 10.4.1 Middle East & Africa Biosimilar Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Biosimilar Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AET BioTech 11.1.1 AET BioTech Company Details 11.1.2 AET BioTech Business Overview 11.1.3 AET BioTech Biosimilar Introduction 11.1.4 AET BioTech Revenue in Biosimilar Business (2016-2021) 11.1.5 AET BioTech Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview 11.2.3 Amgen Biosimilar Introduction 11.2.4 Amgen Revenue in Biosimilar Business (2016-2021) 11.2.5 Amgen Recent Development 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Company Details 11.3.2 Boehringer Ingelheim Business Overview 11.3.3 Boehringer Ingelheim Biosimilar Introduction 11.3.4 Boehringer Ingelheim Revenue in Biosimilar Business (2016-2021) 11.3.5 Boehringer Ingelheim Recent Development 11.4 Coherus Biosciences 11.4.1 Coherus Biosciences Company Details 11.4.2 Coherus Biosciences Business Overview 11.4.3 Coherus Biosciences Biosimilar Introduction 11.4.4 Coherus Biosciences Revenue in Biosimilar Business (2016-2021) 11.4.5 Coherus Biosciences Recent Development 11.5 Fujifilm Kyowa Kirin Biologics 11.5.1 Fujifilm Kyowa Kirin Biologics Company Details 11.5.2 Fujifilm Kyowa Kirin Biologics Business Overview 11.5.3 Fujifilm Kyowa Kirin Biologics Biosimilar Introduction 11.5.4 Fujifilm Kyowa Kirin Biologics Revenue in Biosimilar Business (2016-2021) 11.5.5 Fujifilm Kyowa Kirin Biologics Recent Development 11.6 LG Life Sciences/Mochida Pharmaceutical 11.6.1 LG Life Sciences/Mochida Pharmaceutical Company Details 11.6.2 LG Life Sciences/Mochida Pharmaceutical Business Overview 11.6.3 LG Life Sciences/Mochida Pharmaceutical Biosimilar Introduction 11.6.4 LG Life Sciences/Mochida Pharmaceutical Revenue in Biosimilar Business (2016-2021) 11.6.5 LG Life Sciences/Mochida Pharmaceutical Recent Development 11.7 Momenta Pharmaceuticals 11.7.1 Momenta Pharmaceuticals Company Details 11.7.2 Momenta Pharmaceuticals Business Overview 11.7.3 Momenta Pharmaceuticals Biosimilar Introduction 11.7.4 Momenta Pharmaceuticals Revenue in Biosimilar Business (2016-2021) 11.7.5 Momenta Pharmaceuticals Recent Development 11.8 Oncobiologics 11.8.1 Oncobiologics Company Details 11.8.2 Oncobiologics Business Overview 11.8.3 Oncobiologics Biosimilar Introduction 11.8.4 Oncobiologics Revenue in Biosimilar Business (2016-2021) 11.8.5 Oncobiologics Recent Development 11.9 Pfizer 11.9.1 Pfizer Company Details 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Biosimilar Introduction 11.9.4 Pfizer Revenue in Biosimilar Business (2016-2021) 11.9.5 Pfizer Recent Development 11.10 Samsung Bioepsis 11.10.1 Samsung Bioepsis Company Details 11.10.2 Samsung Bioepsis Business Overview 11.10.3 Samsung Bioepsis Biosimilar Introduction 11.10.4 Samsung Bioepsis Revenue in Biosimilar Business (2016-2021) 11.10.5 Samsung Bioepsis Recent Development 11.11 Sandoz 11.11.1 Sandoz Company Details 11.11.2 Sandoz Business Overview 11.11.3 Sandoz Biosimilar Introduction 11.11.4 Sandoz Revenue in Biosimilar Business (2016-2021) 11.11.5 Sandoz Recent Development 11.12 Zydus Cadila 11.12.1 Zydus Cadila Company Details 11.12.2 Zydus Cadila Business Overview 11.12.3 Zydus Cadila Biosimilar Introduction 11.12.4 Zydus Cadila Revenue in Biosimilar Business (2016-2021) 11.12.5 Zydus Cadila Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Biosimilar Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Tablet Table 3. Key Players of Oral Solution Table 4. Global Biosimilar Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Biosimilar Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Biosimilar Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Biosimilar Market Share by Regions (2016-2021) Table 8. Global Biosimilar Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Biosimilar Market Share by Regions (2022-2027) Table 10. Biosimilar Market Trends Table 11. Biosimilar Market Drivers Table 12. Biosimilar Market Challenges Table 13. Biosimilar Market Restraints Table 14. Global Biosimilar Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Biosimilar Market Share by Players (2016-2021) Table 16. Global Top Biosimilar Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar as of 2020) Table 17. Ranking of Global Top Biosimilar Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Biosimilar Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Biosimilar Product Solution and Service Table 21. Date of Enter into Biosimilar Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Biosimilar Market Size by Type (2016-2021) (US$ Million) Table 24. Global Biosimilar Revenue Market Share by Type (2016-2021) Table 25. Global Biosimilar Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Biosimilar Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Biosimilar Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Biosimilar Revenue Market Share by Application (2016-2021) Table 29. Global Biosimilar Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Biosimilar Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Biosimilar Market Size by Type (2016-2021) (US$ Million) Table 32. North America Biosimilar Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Biosimilar Market Size by Application (2016-2021) (US$ Million) Table 34. North America Biosimilar Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Biosimilar Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Biosimilar Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Biosimilar Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Biosimilar Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Biosimilar Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Biosimilar Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Biosimilar Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Biosimilar Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Biosimilar Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Biosimilar Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Biosimilar Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Biosimilar Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Biosimilar Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Biosimilar Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Biosimilar Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Biosimilar Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Biosimilar Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Biosimilar Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Biosimilar Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Biosimilar Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Biosimilar Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Biosimilar Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Biosimilar Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Biosimilar Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Biosimilar Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Biosimilar Market Size by Country (2022-2027) & (US$ Million) Table 61. AET BioTech Company Details Table 62. AET BioTech Business Overview Table 63. AET BioTech Biosimilar Product Table 64. AET BioTech Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 65. AET BioTech Recent Development Table 66. Amgen Company Details Table 67. Amgen Business Overview Table 68. Amgen Biosimilar Product Table 69. Amgen Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 70. Amgen Recent Development Table 71. Boehringer Ingelheim Company Details Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Biosimilar Product Table 74. Boehringer Ingelheim Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 75. Boehringer Ingelheim Recent Development Table 76. Coherus Biosciences Company Details Table 77. Coherus Biosciences Business Overview Table 78. Coherus Biosciences Biosimilar Product Table 79. Coherus Biosciences Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 80. Coherus Biosciences Recent Development Table 81. Fujifilm Kyowa Kirin Biologics Company Details Table 82. Fujifilm Kyowa Kirin Biologics Business Overview Table 83. Fujifilm Kyowa Kirin Biologics Biosimilar Product Table 84. Fujifilm Kyowa Kirin Biologics Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 85. Fujifilm Kyowa Kirin Biologics Recent Development Table 86. LG Life Sciences/Mochida Pharmaceutical Company Details Table 87. LG Life Sciences/Mochida Pharmaceutical Business Overview Table 88. LG Life Sciences/Mochida Pharmaceutical Biosimilar Product Table 89. LG Life Sciences/Mochida Pharmaceutical Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 90. LG Life Sciences/Mochida Pharmaceutical Recent Development Table 91. Momenta Pharmaceuticals Company Details Table 92. Momenta Pharmaceuticals Business Overview Table 93. Momenta Pharmaceuticals Biosimilar Product Table 94. Momenta Pharmaceuticals Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 95. Momenta Pharmaceuticals Recent Development Table 96. Oncobiologics Company Details Table 97. Oncobiologics Business Overview Table 98. Oncobiologics Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 99. Oncobiologics Recent Development Table 100. Pfizer Company Details Table 101. Pfizer Business Overview Table 102. Pfizer Biosimilar Product Table 103. Pfizer Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 104. Pfizer Recent Development Table 105. Samsung Bioepsis Company Details Table 106. Samsung Bioepsis Business Overview Table 107. Samsung Bioepsis Biosimilar Product Table 108. Samsung Bioepsis Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 109. Samsung Bioepsis Recent Development Table 110. Sandoz Company Details Table 111. Sandoz Business Overview Table 112. Sandoz Biosimilar Product Table 113. Sandoz Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 114. Sandoz Recent Development Table 115. Zydus Cadila Company Details Table 116. Zydus Cadila Business Overview Table 117. Zydus Cadila Biosimilar Product Table 118. Zydus Cadila Revenue in Biosimilar Business (2016-2021) & (US$ Million) Table 119. Zydus Cadila Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Biosimilar Market Share by Type: 2020 VS 2027 Figure 2. Tablet Features Figure 3. Oral Solution Features Figure 4. Global Biosimilar Market Share by Application: 2020 VS 2027 Figure 5. Hospital Pharmacy Case Studies Figure 6. Retail Pharmacy Case Studies Figure 7. Online Pharmacy Case Studies Figure 8. Biosimilar Report Years Considered Figure 9. Global Biosimilar Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Biosimilar Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Biosimilar Market Share by Regions: 2020 VS 2027 Figure 12. Global Biosimilar Market Share by Regions (2022-2027) Figure 13. Global Biosimilar Market Share by Players in 2020 Figure 14. Global Top Biosimilar Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Biosimilar Revenue in 2020 Figure 16. Global Biosimilar Revenue Market Share by Type (2016-2021) Figure 17. Global Biosimilar Revenue Market Share by Type (2022-2027) Figure 18. North America Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Biosimilar Market Share by Type (2016-2027) Figure 20. North America Biosimilar Market Share by Application (2016-2027) Figure 21. North America Biosimilar Market Share by Country (2016-2027) Figure 22. United States Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Biosimilar Market Share by Type (2016-2027) Figure 26. Europe Biosimilar Market Share by Application (2016-2027) Figure 27. Europe Biosimilar Market Share by Country (2016-2027) Figure 28. Germany Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Biosimilar Market Share by Type (2016-2027) Figure 36. Asia-Pacific Biosimilar Market Share by Application (2016-2027) Figure 37. Asia-Pacific Biosimilar Market Share by Region (2016-2027) Figure 38. China Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Biosimilar Market Share by Type (2016-2027) Figure 46. Latin America Biosimilar Market Share by Application (2016-2027) Figure 47. Latin America Biosimilar Market Share by Country (2016-2027) Figure 48. Mexico Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Biosimilar Market Share by Type (2016-2027) Figure 52. Middle East & Africa Biosimilar Market Share by Application (2016-2027) Figure 53. Middle East & Africa Biosimilar Market Share by Country (2016-2027) Figure 54. Turkey Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Biosimilar Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. AET BioTech Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 58. Amgen Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 59. Boehringer Ingelheim Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 60. Coherus Biosciences Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 61. Fujifilm Kyowa Kirin Biologics Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 62. LG Life Sciences/Mochida Pharmaceutical Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 63. Momenta Pharmaceuticals Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 64. Oncobiologics Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 65. Pfizer Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 66. Samsung Bioepsis Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 67. Sandoz Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 68. Zydus Cadila Revenue Growth Rate in Biosimilar Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

AET BioTech Amgen Boehringer Ingelheim Coherus Biosciences Fujifilm Kyowa Kirin Biologics LG Life Sciences/Mochida Pharmaceutical Momenta Pharmaceuticals Oncobiologics Pfizer Samsung Bioepsis Sandoz Zydus Cadila